Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiotensin Receptor Antagonists”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Post-approval studies (Phase 4)Study completedNCT01675362
What this trial is testing

Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?

Who this might be right for
Kidney Calculi
Mansoura University 160
Not applicableUnknownNCT00437775
What this trial is testing

ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects

Who this might be right for
Diabetes Mellitus Type 2
Assaf-Harofeh Medical Center 300
Large-scale testing (Phase 3)Study completedNCT02040441
What this trial is testing

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Who this might be right for
Diabetic NephropathyDiabetic Retinopathy
Peter Rossing 1,777
Early research (Phase 1)Study completedNCT01771783
What this trial is testing

RAS-Peptide-Profile Study in Healthy Male Subjects

Who this might be right for
RAS Peptide Profile in Healthy Volunteers
University Hospital, Basel, Switzerland 12
Post-approval studies (Phase 4)Study completedNCT01964079
What this trial is testing

Comparision of Blood Pressure Variability Between Amlodipine and Losartan

Who this might be right for
Hypertension
Wonju Severance Christian Hospital 144
Post-approval studies (Phase 4)Study completedNCT01340326
What this trial is testing

The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

Who this might be right for
Myocardial Infarction
Dong-A University 800
Testing effectiveness (Phase 2)Study completedNCT01613118
What this trial is testing

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Travere Therapeutics, Inc. 109
Large-scale testing (Phase 3)Looking for participantsNCT05457283
What this trial is testing

Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Who this might be right for
Chronic Kidney DiseaseProteinuriaChildren
Bayer 100
Not applicableUnknownNCT04374695
What this trial is testing

Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19

Who this might be right for
COVID-19
Versailles Hospital 700
Large-scale testing (Phase 3)Study completedNCT00519870
What this trial is testing

Losartan Therapy in Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Baskent University
Not applicableStudy completedNCT04467931
What this trial is testing

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Who this might be right for
HypertensionCOVID
University of Utah 22,213
Post-approval studies (Phase 4)WithdrawnNCT03640221
What this trial is testing

Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.

Who this might be right for
HypertensionDiabetes Mellitus, Type 2
Cedars-Sinai Medical Center
Post-approval studies (Phase 4)Ended earlyNCT04335786
What this trial is testing

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Who this might be right for
Acute Respiratory Distress SyndromeSARS-CoV-2COVID+2 more
Radboud University Medical Center 23
Post-approval studies (Phase 4)Study completedNCT00134160
What this trial is testing

OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

Who this might be right for
HypertensionCardiovascular Diseases
OSCAR Study 1,000
Large-scale testing (Phase 3)Study completedNCT00001629
What this trial is testing

The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

Who this might be right for
AtherosclerosisHeart Failure, CongestiveHypertension+1 more
National Heart, Lung, and Blood Institute (NHLBI) 49
Post-approval studies (Phase 4)Study completedNCT00720226
What this trial is testing

Efficacy of Losartan in Preventing Progression of COPD

Who this might be right for
COPDEmphysemaChronic Bronchitis+1 more
Johns Hopkins University 106
Post-approval studies (Phase 4)Study completedNCT00492128
What this trial is testing

Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

Who this might be right for
Hypertension
Yokohama City University Medical Center 196
Post-approval studies (Phase 4)Study completedNCT03476616
What this trial is testing

Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients

Who this might be right for
HypertensionObesity
Hippocration General Hospital 198
Large-scale testing (Phase 3)WithdrawnNCT00089518
What this trial is testing

Optimal Treatment for Kidney Disease in HIV Infected Adults

Who this might be right for
HIV InfectionsKidney Disease
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT01113047
What this trial is testing

Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

Who this might be right for
Essential Hypertension
Novartis 347
Next Page